U.S. Department of Health & Human Services
Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary
Institute for Clinical and Economic Review, issuing body. Midwest Comparative Effectiveness Public Advisory Council, issuing body.
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 7, 2018
Cystic Fibrosis -- drug therapy
Cystic Fibrosis Transmembrane Conductance Regulator -- therapeutic use
Clinical Trials as Topic
Cost of Illness
Cystic Fibrosis Transmembrane Conductance Regulator -- adverse effects
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license.
1 online resource (1 PDF file (various pagings))
NLM Unique ID:
See catalog record
Metadata (Dublin Core)